CMC-2.24 (traverse biosciences)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCMC-2.24 (traverse biosciences)
Drug Alias NameCMC-2.24TRB-N0224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase modulators
TargetsMatrix metalloproteinase
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTraverse Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTraverse Biotech Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A